Revmoxicam (meloxicam) tablets 7.5 mg. №20

$11.00

Manufacturer: Ukraine

Purpose: Inhibits COX-2 enzyme for anti-inflammatory relief in arthritis and pain management.

Description

Revmoxicam (Meloxicam) Tablets 7.5 mg. №20

Ingredients:

Each tablet contains 7.5 mg of Meloxicam.

Dosage:

The recommended dosage is one tablet daily. It is important to follow the instructions provided by your healthcare provider.

Indications:

Revmoxicam tablets are indicated for the relief of pain and inflammation associated with osteoarthritis and rheumatoid arthritis.

Contraindications:

Do not use Revmoxicam if you have a history of allergic reactions to meloxicam or other NSAIDs. It is important to consult your doctor before starting this medication.

Directions:

Take one tablet by mouth with a full glass of water. It can be taken with or without food, but it is recommended to take it at the same time each day.

Scientific Evidence:

Meloxicam, the active ingredient in Revmoxicam tablets, is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing hormones that cause inflammation and pain in the body. Studies have shown that meloxicam is effective in managing pain and inflammation in patients with osteoarthritis and rheumatoid arthritis. Research published in the Journal of Clinical Rheumatology demonstrated the efficacy of meloxicam in improving joint function and reducing pain levels in patients with osteoarthritis.

Additional Information:

It is important to inform your healthcare provider about any other medications you are taking before starting Revmoxicam tablets. Common side effects may include stomach upset, nausea, and dizziness. If you experience any severe side effects, contact your doctor immediately.

Clinical trials have shown that meloxicam is well-tolerated and effective in the management of pain and inflammation associated with arthritis. A study published in the Journal of Rheumatology compared the effectiveness of meloxicam with other NSAIDs and found it to be equally effective with a lower risk of gastrointestinal side effects.